AR002541A1 - Inhibidores de la ribonucleotido-reductasa de herpes. - Google Patents

Inhibidores de la ribonucleotido-reductasa de herpes.

Info

Publication number
AR002541A1
AR002541A1 ARP960103241A AR10324196A AR002541A1 AR 002541 A1 AR002541 A1 AR 002541A1 AR P960103241 A ARP960103241 A AR P960103241A AR 10324196 A AR10324196 A AR 10324196A AR 002541 A1 AR002541 A1 AR 002541A1
Authority
AR
Argentina
Prior art keywords
reductase inhibitors
herpes ribonucleotide
ribonucleotide
herpes
alkyl
Prior art date
Application number
ARP960103241A
Other languages
English (en)
Inventor
Jean Andre Gauthier
Neil Moss
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of AR002541A1 publication Critical patent/AR002541A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen aquí compuestos de la fórmula (I), en la que R1 es hidrógeno o alquilo (1-4C), R2 es alquilo (1-4C) o una de sus sales terapéuticamenteaceptables. Los compuestos son útiles para tratar infecciones por herpes.
ARP960103241A 1995-06-23 1996-06-21 Inhibidores de la ribonucleotido-reductasa de herpes. AR002541A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002152541A CA2152541C (en) 1995-06-23 1995-06-23 Herpes ribonucleotide reductase inhibitors

Publications (1)

Publication Number Publication Date
AR002541A1 true AR002541A1 (es) 1998-03-25

Family

ID=4156109

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103241A AR002541A1 (es) 1995-06-23 1996-06-21 Inhibidores de la ribonucleotido-reductasa de herpes.

Country Status (11)

Country Link
US (1) US5672586A (es)
EP (1) EP0837845B1 (es)
JP (1) JPH11508246A (es)
AR (1) AR002541A1 (es)
AT (1) ATE209628T1 (es)
AU (1) AU5097796A (es)
CA (1) CA2152541C (es)
DE (1) DE69617433T2 (es)
IL (1) IL118705A0 (es)
WO (1) WO1997000855A1 (es)
ZA (1) ZA965272B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4814432A (en) * 1987-05-22 1989-03-21 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
EP0411334B1 (en) * 1989-07-07 1995-02-22 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain
US5110799A (en) * 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
ATE169931T1 (de) * 1992-03-12 1998-09-15 Boehringer Ingelheim Ca Ltd Isosterische peptidderivate gegen herpes
US5574015A (en) * 1992-03-12 1996-11-12 Bio-Mega/Boehringer Ingelheim Research Inc. Isosteric antiherpes peptide derivatives
EP0560274B1 (en) * 1992-03-12 1998-06-24 Boehringer Ingelheim (Canada) Ltd. Antiherpes peptide derivatives having a ureido N-terminus
PT618226E (pt) * 1993-03-03 2001-03-30 Boehringer Ingelheim Ca Ltd Inibidores de ribonucleotido redutase de virus do herpes

Also Published As

Publication number Publication date
CA2152541C (en) 1998-12-15
EP0837845B1 (en) 2001-11-28
ATE209628T1 (de) 2001-12-15
AU5097796A (en) 1997-01-22
DE69617433T2 (de) 2002-06-27
IL118705A0 (en) 1996-10-16
DE69617433D1 (de) 2002-01-10
US5672586A (en) 1997-09-30
CA2152541A1 (en) 1996-12-24
EP0837845A1 (en) 1998-04-29
MX9710147A (es) 1998-03-31
JPH11508246A (ja) 1999-07-21
ZA965272B (en) 1996-12-23
WO1997000855A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
MX9303100A (es) Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).
ES2176402T3 (es) Compuestos sulfatos de 2,2-difluoro-3-carbomoil-ribosa y procedimientopara la preparacion de beta-nucleosidos.
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
PL328270A1 (en) Derivatives of sulphonated amino acids and inhibitors of metaloproteinase containing such derivatives
DK0749424T3 (da) Naphthalenderivater som prostaglandin-I2-agonister
NO950533L (no) Hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere
AR006390A1 (es) Derivados de lactama
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
DE69812634D1 (de) Metalloproteinase-inhibitoren
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
NO954609L (no) Niopecotiske syrederivater som antitrombiske forbindelser
ES2191109T3 (es) Inhibidores de proteasas de guanidino.
ES2182021T3 (es) Oxazolinas artropodicidas.
AR002541A1 (es) Inhibidores de la ribonucleotido-reductasa de herpes.
ES2174034T3 (es) Naftilglioxamidas como inhibidores de spla2
ES2182090T3 (es) Nuevos derivados de pirrol.
ES2057415T3 (es) Derivados biciclicos.
SV1998000088A (es) Compuestos farmaceuticos
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
CO4700429A1 (es) Un procedimiento para la preparacion de monohidrato de lora- carbef
DE69422629T2 (de) Indolderivate als 5-alpha-reductase-1 inhibitoren
AR014135A1 (es) Profarmacos de lobucavir y metodos de uso